3D structure of an antibody candidate is shown alongside the protein of SARS-CoV-

LLNL’s New ML Platform Generates Novel COVID-19 Antibody Sequences for Experimental Testing

Friday, May 1, 2020
LLNL researchers have identified an initial set of therapeutic antibody sequences, designed in a few weeks using machine learning and supercomputing, aimed at binding and neutralizing SARS-CoV-2.